Recently Updated Advisory Committee Materials

Recently Updated Advisory Committee Materials

* Posted on April 09, 2010
Pharmaceutical Science and Clinical Pharmacology Advisory Committee
1. Briefing Information for the April 14, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee1

2. Briefing Information for the April 13, 2010 Meeting of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee2

3. FDA Briefing Information for the April 13, 2010 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (PDF – 603KB3 (PDF - 603KB)
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM207955.pdf

* Advisory Committee Calendar
June 10, 2010: Peripheral and Central Nervous System Drugs Advisory
http://www.fda.gov/AdvisoryCommittees/Calendar/ucm207667.htm

** Committee Meeting Announcement4
-Posted on April 08, 2010
Pediatric Advisory Committee
1. Briefing Information for the March 22, 2010 Meeting of the Pediatric Advisory Committee5

2. Testimony of Sidney M. Wolfe, M.D.6 (PDF - 218KB)
Additional Evidence of the Cancer Risk of Calcineurin Inhibitor Medications (tacrolimus) and Elidel @imecrolimus)- March 22,2010
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM207890.pdf

3. Elidel (pimecrolimus) 1% cream: Novartis Presentation Slides7 (PDF - 103KB)
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM207871.pdf

4. Open Public Hearing Witness List8

5. Melanocytic Lesions in Children and Adolescents: Astellas Presentation Slides9 (PDF - 46KB)
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM207878.pdf


*** Cardiovascular and Renal Drugs Advisory Committee
Minutes for the March 01, 2010 Meeting of the Cardiovascular and Renal Drugs Advisory Committee10 (PDF - 31KB)

open here to see all the documents providing from FDA Commitees:
Recently Updated Advisory Committee Materials